PLRX
Price
$1.63
Change
+$0.02 (+1.24%)
Updated
Jun 6 closing price
Capitalization
99.14M
64 days until earnings call
VCEL
Price
$43.30
Change
-$0.10 (-0.23%)
Updated
Jun 6 closing price
Capitalization
2.19B
52 days until earnings call
Interact to see
Advertisement

PLRX vs VCEL

Header iconPLRX vs VCEL Comparison
Open Charts PLRX vs VCELBanner chart's image
Pliant Therapeutics
Price$1.63
Change+$0.02 (+1.24%)
Volume$956.8K
Capitalization99.14M
Vericel
Price$43.30
Change-$0.10 (-0.23%)
Volume$239.38K
Capitalization2.19B
PLRX vs VCEL Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. VCEL commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Buy and VCEL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (PLRX: $1.35 vs. VCEL: $42.10)
Brand notoriety: PLRX and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 98% vs. VCEL: 88%
Market capitalization -- PLRX: $99.14M vs. VCEL: $2.19B
PLRX [@Biotechnology] is valued at $99.14M. VCEL’s [@Biotechnology] market capitalization is $2.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, VCEL is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 3 TA indicator(s) are bullish while VCEL’s TA Score has 2 bullish TA indicator(s).

  • PLRX’s TA Score: 3 bullish, 5 bearish.
  • VCEL’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than VCEL.

Price Growth

PLRX (@Biotechnology) experienced а +1.50% price change this week, while VCEL (@Biotechnology) price change was +2.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

PLRX is expected to report earnings on Aug 11, 2025.

VCEL is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($2.19B) has a higher market cap than PLRX($99.1M). VCEL YTD gains are higher at: -23.329 vs. PLRX (-89.749). VCEL has higher annual earnings (EBITDA): 16.6M vs. PLRX (-205.16M). PLRX has more cash in the bank: 356M vs. VCEL (116M). PLRX has less debt than VCEL: PLRX (60.2M) vs VCEL (98.8M). VCEL has higher revenues than PLRX: VCEL (237M) vs PLRX (0).
PLRXVCELPLRX / VCEL
Capitalization99.1M2.19B5%
EBITDA-205.16M16.6M-1,236%
Gain YTD-89.749-23.329385%
P/E RatioN/A868.20-
Revenue0237M-
Total Cash356M116M307%
Total Debt60.2M98.8M61%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXVCEL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
80%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
75%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 24 days ago
76%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 25 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
77%
Aroon
ODDS (%)
Bullish Trend 12 days ago
74%
Bearish Trend 12 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+5.47%
LXRX - PLRX
42%
Loosely correlated
+1.36%
SRRK - PLRX
40%
Loosely correlated
-5.28%
OCUL - PLRX
39%
Loosely correlated
+13.69%
RIGL - PLRX
38%
Loosely correlated
-2.19%
BAIVF - PLRX
38%
Loosely correlated
N/A
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with BEAM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+0.07%
BEAM - VCEL
36%
Loosely correlated
-0.88%
RXRX - VCEL
35%
Loosely correlated
+0.11%
MNMD - VCEL
35%
Loosely correlated
+0.14%
PLRX - VCEL
34%
Loosely correlated
+5.47%
CRBU - VCEL
33%
Loosely correlated
+2.75%
More